Testing ELLASI intervention for polytrauma patients in the emergency department
Effectiveness of ELLASI Intervention Towards Response Time, Deterioration, and Metabolic Status of Polytrauma Patients in the Emergency Department
This study is testing if a new treatment called ELLASI can help polytrauma patients in the emergency department do better than those who get standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Indonesia University Academic / other |
| Locations | 1 site (Jakarta Pusat, Jawa Barat) |
| Trial ID | NCT06351826 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the ELLASI intervention on polytrauma patients in the emergency department. It compares response times, deterioration scores, and metabolic status between patients receiving ELLASI and those receiving standard care. The ELLASI intervention includes airway evaluation, patient positioning, and stabilization techniques. The goal is to determine if ELLASI can improve outcomes for polytrauma patients who have not received prior medical treatment.
Who should consider this trial
Good fit: Ideal candidates are polytrauma patients who have not received any medical treatment prior to the intervention.
Not a fit: Patients who are unwilling to participate or have had prior medical treatment will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the emergency care and outcomes for polytrauma patients.
How similar studies have performed: While similar interventions have been explored, the specific ELLASI approach is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Polytrauma patients * Have not received medical treatment before Exclusion Criteria: * Canceled registration * Polytrauma patients who are unwilling to participate in the study
Where this trial is running
Jakarta Pusat, Jawa Barat
- Rscm — Jakarta Pusat, Jawa Barat, Indonesia (Recruiting)
Study contacts
- Study coordinator: Nurlaelah
- Email: adeleyla77@gmail.com
- Phone: 06281299225207
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.